1-O-Hexadecyl-2-lyso-glycero-3-phosphorylcholine
| Code | Size | Price |
|---|
| TAR-T29308-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T29308-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
1-O-Hexadecyl-2-lyso-glycero-3-phosphorylcholine is a biologically inactive precursor of platelet activating factor.
CAS:
52691-62-0
Molecular Weight:
481.65
Purity:
0.98
SMILES:
O(C[C@@H](COCCCCCCCCCCCCCCCC)O)P(OCC[N+](C)(C)C)(=O)[O-]
References
Qian CG, Lee TC, Snyder F. Metabolism of platelet activating factor (PAF) and related ether lipids by neonatal rat myocytes. J Lipid Mediat. 1989 Mar-Apr;1(2):113-23. PubMed PMID: 2519887.
Li Y, Hou M, Wang JG, Wang T, Wan J, Jiao BH, Lin ZF. Changes of lymph metabolites in a rat model of sepsis induced by cecal ligation and puncture. J Trauma Acute Care Surg. 2012 Dec;73(6):1545-52. doi: 10.1097/TA.0b013e31826fc9e7. PubMed PMID: 23147180.
Mickelson JK, Simpson PJ, Lucchesi BR. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. J Mol Cell Cardiol. 1988 Jun;20(6):547-61. PubMed PMID: 3216407.